Sign Up to like & get
recommendations!
0
Published in 2017 at "Pancreas"
DOI: 10.1097/mpa.0000000000000850
Abstract: Abstract There have been significant developments in diagnostic and therapeutic options for patients with neuroendocrine tumors (NETs). Key phase 3 studies include the CLARINET trial, which evaluated lanreotide in patients with nonfunctioning enteropancreatic NETs; the…
read more here.
Keywords:
neuroendocrine tumor;
midgut;
north american;
neuroendocrine tumors ... See more keywords